Central Nervous System Disorders

Central nervous system (CNS) disorders are the leading therapeutic category of the US pharmaceutical market. For example, 2.5 million people in the US suffer from epilepsy and close to 30 million people in the US suffer from depression - and these are just two of the common CNS disorders.

Given the magnitude of the problem and the vast number of patients affected by CNS disorders, we're constantly looking for new ways to improve treatments across various CNS diseases. For example, we've developed novel approaches for the treatment of epilepsy and migraine.

We're applying technology and innovative methods to transform how patients are treated, with the goal of better care and quality of life for CNS patients. Click on the links to learn more about our work in specific CNS areas.